HR. 1796In Committee
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
Establishes federal activities for sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment programs
Plain-English overview
What this bill does
Establishes federal activities for sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment programs
Key points
- Establish blood disorder research programs
- Authorize disease surveillance activities
- Expand prevention and treatment efforts
Current status
Where it stands
Status
In Committee
Latest action
2025-03-03 — Referred to the House Committee on Energy and Commerce.
Related context
Topics and policy areas
undefinedBlood and blood diseasesGeneticsHealthHealth promotion and preventive careHereditary and development disordersMedical researchResearch administration and funding
